Robeco Institutional Asset Management B.V., a registered investment adviser, initiated a new position in Eli Lilly and Company (NYSE:LLY) during Q4 2025, according to its most recent 13F filing with the Securities and Exchange Commission.
The institutional investor purchased 726,465 shares of the Healthcare company, valued at approximately $780.7M as of the filing date.
Eli Lilly and Company's stock currently trades at $1077.63 with a market capitalization of $906.5B.


